Announcements Trials
Browse Landscape

Phase

Phase 2 117Phase 1 106Phase 1/2 58Phase NA 39Phase 3 15Phase EARLY_PHASE1 3Phase 4 3Phase 2/3 3

Status

Recruiting 47Completed 35Unknown 28Not yet recruiting 20Terminated 14Withdrawn 3Active not recruiting 2Suspended 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 20Gastrointestinal 18CNS 14Genitourinary 10Thoracic 9Head & Neck 9Tumor-Agnostic 8Gynecologic 8Dermatologic 7Lymphoid 6Sarcoma 5Plasma cell 5Other 4Other hematologic neoplasm 3Other solid neoplasm 2Other neoplasm 1NET 1Myeloid 1Endocrine 1Classical hematology 1

Conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Myeloid, Acute 1Hematologic Neoplasms 1

Interventions

pembrolizumab 1Hyperthermia, Induced 1Diathermy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Withdrawn × Other hematologic neoplasm × Clear all
NCT04860817 2022-11-29

A Study of Anti-CD7 CAR-T Cells in Pediatric and Young Adult Patients With Relapse and Refractory T-ALL/ T-LBL

920th Hospital of Joint Logistics Support Force of People's Liberation Army of China

Phase EARLY_PHASE1 Withdrawn
LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT04803630 2022-05-12

Thermal Therapy for the Treatment of Depression in Cancer Survivors, the S-WARM Study

Roswell Park Cancer Institute

Phase EARLY_PHASE1 Withdrawn
Other hematologic neoplasm

Hematologic Neoplasms

NCT03291353 2019-04-19

Phase 0- Pilot Study of Pembrolizumab on Immune Cells in Patient With Refractory Acute Myeloid Leukemia

University of Pittsburgh

Phase EARLY_PHASE1 Withdrawn
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡